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This study aims to evaluate the effect of anti-Streptococcus mutans IgY gel on
quantity of S. mutans on rats’ tooth surface. Sprague Dawley rats were exposed intra-
orally with S. mutans Xc and were fed a caries-inducing diet 2000. The 24 rats were
divided into four groups: group A had their teeth coated with IgY gel; group B
received sterilized water as a control; group C had their teeth coated with IgY gel
starting on the 29th day; and group D had their teeth coated with a gel without IgY.
Plaque samples were swabbed from the anterior teeth for S. mutans colony quantiﬁ-
cation, and saliva was collected to measure immunoreactivity by enzyme-linked
immunosorbent assay. The results indicated that the quantity of S. mutans in rats
treated with IgY gel showed signiﬁcant difference compared with the controls. After
coating with IgY anti-S. mutans gel, the mean immunoreactivity in rat saliva was
higher than that of the no treatment group. In conclusion, topical application with anti-
S. mutans IgY gel reduced the quantity of S. mutans on the tooth surface.
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Introduction
Dental caries is an infectious disease with a high estimated prevalence in
Indonesia. According to Indonesian Basic Health Research conducted in 2007 by
the Department of Health in Indonesia, the active caries prevalence of the
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population aged 12 years and older reached 46.50%, and 27.90% of subjects
were caries free [1]. Caries involves many factors other than Streptococcus mutans
(S. mutans); these include plaque accumulation, carbohydrate intake, acidic diet, and
conditioning saliva [2–5]. The immune system plays a role in the prevention of
cariogenic processes, along with other components that impede bacterial growth
[6, 7]. Common caries prevention involves the use of ﬂuoride and chlorhexidine.
Another caries prevention method is passive immunization by inhibiting bioﬁlm
formation without eliminating the associated micro-organisms from the oral cavity
[8]. This immunological approach that protects teeth from caries acts by preventing
bacterial interaction with dental surfaces. Antibodies can block the interactions
between S. mutans adhesions with receptors involved in dental surface colonization
or accumulation (glucan binding) or impede the activation of the glucosyltransferase
(GTF) [9]. The passive immunization method is considered to be safer and has gained
more attention from experts than the active immunization method [10–12]. Various
studies have shown the effectiveness of passive immunization in caries prevention
both in animals and in humans. IgY antibody, in the form of monoclonal antibody,
has been used in passive immunization as well, and it is obtained from egg yolk,
colostrum, or cow milk concentrate [11, 13, 14]. Shimazaki et al. [10] have
successfully used bovine milk containing antibody against the fusion protein antigen
A of the S. mutans serotype c and glucan-binding (GB) domain of GTF-I (PAc-GB)
as a source of passive immunization to prevent the recolonization of S. mutans.
The applied technology of IgY has proven to be more beneﬁcial than
conventional antibody products obtained from rabbits or other mammals. Chicken
eggs produce more antibodies than do mammals. One chicken produces antibodies
equal to that produced by 10–20 rabbits. Moreover, it is easier to collect eggs than to
obtain blood from 10 rabbits. Each egg yolk can also be puriﬁed to produce
50–100 mg of IgY. Generally, IgY production is cheaper, and collecting eggs is
non-invasive; furthermore, IgY isolation is fast and easy. Another beneﬁt is that
fewer antigens are required to titre IgY over time [15–18]. IgY as an anti-cariogenic
agent that has also been examined in the form of toothpaste [19]. Research
conducted by Hatta et al. [20] showed a decrease in S. mutans levels in saliva
from a volunteer group that received mouthwash containing anti-S. mutans whole-
cell IgY. Research conducted by Paau and Rong-Jiang [21] in 2006 showed that
the IgY-anti-S. mutans toothpaste decreased the percentage of S. mutans among the
total anaerobic bacteria found in both saliva and plaque samples. Similar to previous
research, Otake et al. [22] used anti-S. mutans whole-cell IgY in the form of frozen
egg yolk in the rat diet. However, the colony count of S. mutanswas not signiﬁcantly
different after this intervention. This might have been caused by the shortened
contact time of IgY in the mouth. IgY application in the form of gel as a protective
and curative strategy against dental caries, however, has not yet been studied.
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Materials and methods
Preparation of IgY gel
Anti-S. mutans IgY gel was produced by the Pharmacy Laboratory of the
Faculty of Medicine, Universitas Indonesia. It consisted of a water-based CMC
(carboxy methyl cellulose) gel that was mixed with water-soluble fraction (WSF)
IgY powder. WSF powder was prepared by the Institute of Agriculture in Bogor
using the egg yolks of immunized hens and was puriﬁed using the EGGSTRACT
puriﬁcation kit. The speciﬁcity of the IgY antibody was examined using the
Ouchterlony test with rabbit antiserum against the chicken serum IgG and mouse
IgG. Speciﬁc binding was only observed with the anti-chicken serum IgG. The
conﬁrmation test of the stability of gel production involved the immunoreactivity
of IgY, which was checked after storage for 30 days. The enzyme-linked
immunosorbent assay (ELISA) technique was used to determine the lowest
concentrations of anti-S. mutans IgY that still showed immunoreactivity against
S. mutans [23].
Experimental rat caries model
The experiment used a caries model in Sprague Dawley rats which were
inoculated with S. mutans Xc (the S. mutans serotype c kindly provided by
Yamashita, Niigata University, Japan). The coating method was conducted once
per day in the labial buccal part of the rats’ teeth (Figure 1). A plaque swab sample
was taken from the anterior teeth for the colony forming unit (CFU) test [22]. To
test the anti-cariogenic activity of IgY antibodies in vivo, the experimental rat
caries model was used. Speciﬁc pathogen-free Sprague Dawley rats (aged 20 days)
were treated with ampicillin and chloramphenicol for 3 days to eliminate the
microbial ﬂora. Rat chow was pulverized and mixed with 1 g of each individual
antibiotic per 1 kg of diet. This treatment reduced the number of oral micro-
organisms when the oral swabs were obtained from the individual rats and
examined on plates containing TSB agar. S. mutans was not detected in the oral
cavity. Twenty-four Sprague Dawley rats were selected from the initial group of
rats. The rats were then randomly separated into several experimental groups, with
each group containing six rats (Figure 1). All rats were fed a modiﬁed diet
2000 (M2000) consisting of 56% sucrose [24]. The rats were then infected with
S. mutans Xc (c) strains (1 mg/ml) by pipette (50 μl of 1 × 1011 CFU/ml) at
24 days of age (Figure 1). Each day, two groups of rats were given coated gels
containing 2% IgY anti-S. mutans Xc, which was started on the ﬁrst day for
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group A and on the 29th day for group C. Among the control group animals, group
B received no gel coating, while group D rats were coated daily with plain gel. All
rats were sacriﬁced at 78 days of age or on day 56 of the experimental protocol,
and oral swabs were taken to conﬁrm the colonization of the inoculum on days 11
and 34. Approval for the in vivo rat research project was obtained from the Ethics
Committee of the Faculty of Dentistry, Universitas Indonesia. Twenty-four
Sprague Dawley rats were then selected from the initial group of rats.
Determination of immunoreactivity of rat saliva
To determine the immunoreactivity of the non-stimulated saliva, samples
were collected from each rat after daily IgY gel coating and were subsequently
evaluated by ELISA. The rat saliva volume measurement was conducted while the
rats were still unconscious. Saliva was obtained using pipettes with 3 suctions over
3 min. The collected material was then placed in properly labeled sterile tubes
containing 50 μl of phosphate-buffered saline (PBS). The samples were stored at
−20 °C before further examination and later processed at the Oral Biology
Laboratory of the Faculty of Dentistry, University of Indonesia. The time course
of the antibody levels in the egg yolk against S. mutans (c) was evaluated using the
ELISA method as described by Bachtiar et al. [25]. S. mutans antigen was
Figure 1. Summary of in vivo experiment protocol in Sprague Dawley rat
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suspended in 0.1 mol/l carbonate buffer (pH 9.6). This antigen suspension at
100 μl/well was used to coat the ELISA plate. Skim milk was used for blocking.
Each well was washed three times with 200 μl of PBS containing 0.05% Tween 20
(PBS-Tween). Rat saliva was diluted 200-fold with PBS-Tween; 100 μl per well in
triplicate was reacted with the antigen for 2 h at 37 °C. After each well was washed
again with PBS-Tween (as mentioned above), alkaline-phosphatase-conjugated
rabbit IgG anti-chicken IgG (Abcam Laboratories, Inc.), diluted 2000-fold with
PBS-Tween (100 μl), was added to each well, and the plate was incubated for 2 h
at 37 °C. Each well was washed with PBS-Tween, and 100 μl of the substrate
solution (p-nitrophenyl phosphate, 1 mg/ml diethanolamine buffer, pH 9.8, Sigma,
St. Louis, MO) was added. The enzyme reaction (30 min at room temperature) was
stopped by adding 5 mol/l NaOH (50 μl/well), and the color that developed was
read at 450 nm with a plate reader (Model 2550, Bio-Rad, Richmond, CA). As a
control, saliva samples obtained from non-IgY or plain gel were used.
Results
Immunoreactivity of the IgY gel
Comparisons of immunoreactivity between anti-S. mutans IgY gel and pure
IgYWSF powder in water were determined using ELISA. The stability of IgY gel
after this study still displayed ELISA reactivity (OD 0.6) after storage for 30 days.
Anti-S. mutans IgY gel reached the same antibody level as that of pure IgY WSF
powder, even after mixing with additional gel materials (Figure 2).
The effect of the anti-S. mutans IgY gel on the S. mutans colony counts is
shown in Figure 3. S. mutans colony counts in group A decreased after coating
the rats’ tooth surfaces with anti-S. mutans IgY gel. Similar results showing a
signiﬁcant difference from the control group were obtained in groups C and D,
which both received gel coating. Interestingly, the most signiﬁcant reduction in
S. mutans count was observed in group A, which had the longest period of gel
application. In contrast, without the coating as a control, S. mutans colony counts
increased signiﬁcantly in group B. These results showed that gel application on
the tooth surfaces provided bioﬁlm protection by reducing S. mutans colony
formation.
The immunoreactivity of anti-S. mutans IgY gel in the rat saliva was
evaluated using ELISA. There was no signiﬁcant difference among the groups
(Figure 4). These results showed that even longer gel application on the tooth
surfaces resulted in an OD below 0.3, and there was no immunoreactivity in the
saliva in all groups.
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Oral examination of group C rats displayed the curative effect of the IgY gel.
This group was coated with gel when white spots started to appear on one of the
rat’s teeth; on the 29th day, two of the rats were observed to have early carious
lesions (data not shown).
Figure 2. Immunoreactivity of IgY in gel (gel IgY), IgY in water (IgY), gel without IgY (gel), and
blank control (blank) against S. mutans antigen. There is no signiﬁcant difference in immunogenicity
between IgY in the form of gel and without gel (water-soluble fraction). Gel IgY and IgY are
immunoreactive against S. mutans antigen compared to the controls (gel and blank)
(p< 0.05). NS: ANOVA post hoc Bonferroni was not signiﬁcantly different (p= 0.51). *: post hoc
test was signiﬁcantly different (p< 0.05)
Figure 3. S. mutans colony counts in the tooth surface of Sprague Dawley rats. Group A: rats coated
with IgY gel; group B: control group without coating; group C: rats coated with IgY gel on the 29th
day; group D: rats coated with gel without IgY. *: signiﬁcant difference was seen (p< 0.05) using
ANOVA post hoc Bonferroni test
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Discussion
Our study showed that there were no differences in the antibody levels
between anti-S. mutans IgY gel and pure IgY WSF powder in water. The mean
values of S. mutans colony counts on the tooth surface of Sprague Dawley rats
showed signiﬁcant differences between the rats coated with IgY gel and the other
groups, whereas no difference was observed in saliva immunoreactivity among the
groups. Previous research has proved that IgY also affects bacterial colonization.
The coating of gel indicated a remineralization process occurring on the teeth [26].
Wen et al. [27] reported that IgY was capable of impeding glucan synthesis by
S. mutans and S. sobrinus. However, several of these studies did not use gel as a
clinical application medium, instead relying on mouthwash or food and toothpaste
[21, 22]. Compared with mouthwash, pure IgY is dissolved in 10 ml of water [20].
This study showed that one gargling requires 2 g or 2% of 10 ml mouthwash,
whereas media in the form of gel requires only 0.2 g or 2% of 1 g of the IgY gel for
a single use. As such, less IgY is required to impede the activity of S. mutanswhen
gels are used.
The selection of IgY gel was also supported by in vitro research needed to
evaluate the biological stability of IgY through an immunoreactivity capability test
of the IgY gel. The IgY gel was stored for 30 days at room temperature [28]. Then,
its immunoreactivity was compared to that of pure IgY in water using ELISA. The
result of this in vitro research showed that the immunoreactivity of the IgY gel was
as stable as that of the IgY without gel. Therefore, the effect of the anti-caries IgY
gel was not lower than that of pure IgY. Similarly, Larsson and Sjoquist [29]
studied pure IgY and conﬁrmed that it can be stored for more than 10 years in
Figure 4. Immunoreactivity of IgY in saliva of the Sprague Dawley rats after 29 days. Control:
medium PBS; group A: rats coated with IgY gel; group B: control animals without coating; group C:
coating with IgY gel on the 29th day; group D: coating with gel without IgY. NS: ANOVA was not
signiﬁcantly different (p> 0.05)
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40 °C without any change in antibody activity. Such stability was sustained for as
long as 6 months at room temperature or for 1 month at 37 °C [28]. The stability of
IgY gel after this study still displayed ELISA reactivity (OD 0.6) after storage for
30 days. This was promising data, as the biological properties of IgY gel without
any preservatives persisted. In addition, it was signiﬁcantly different compared
with the control group. The immunoreactivity properties might have been
enhanced if protein preservatives had been added.
We inoculated S. mutans serotype c in the oral cavities of rats that were
previously administered ampicillin and chloramphenicol for three days to elimi-
nate microbial ﬂora [22] and to prevent the possible impact of infections from
other bacteria. In Figure 3, the group that received the IgY gel coat from the ﬁrst
day had lower levels of S. mutans bacterial colonies than did the group that
received IgY starting on day 29. However, their colony counts were still lower
than those of the group that received the gel without any treatment. S. mutans
colony quantiﬁcation showed the capability of the IgY gel in impeding bioﬁlm
formation at levels that were 100 times higher than those observed in samples
without a gel coating.
Group D, in which plain gel was administered as a control group, showed
surprising data of a signiﬁcant inhibition of S. mutans colonization. The small
number of S. mutans colonies in group D might be due to the role of the increased
volume from rat saliva in all experimental groups which received a gel (data not
shown). A thickening agent such as CMC could stimulate saliva production. The
role of increased saliva production between groups A and D, which received
54 days of gel application, showed almost similar colony count (p= 0.206).
Results of groups A and C, which received IgY gel for 54 days and 27 days,
respectively, showed no signiﬁcant difference (p= 0.96). Duration of using IgY
gel did not strongly inﬂuence the inhibition effect.
We found an increase in saliva volume in all experimental groups when
saliva samples were collected three times without stimulation for 3 min and
immunoreactivity by ELISA was observed. As shown in Figure 4, ELISA showed
that the immunoreactivity of the IgY gel in the rat’s saliva in all experimental
groups was not signiﬁcantly different (OD 0.2–0.3). This means that IgY was not
detected in the saliva after the end of the experiment. Undetected immunoreactivi-
ty of the IgY gel after mixing with saliva was possibly due to enzymes in the rat’s
saliva that were able to destroy proteins. However, the immunoreactivity reduction
of the IgY gel that was without preservatives still showed an ability to block
S. mutans.
According to Chang’s research, the addition of maltose, sucrose, glycine,
and glycerol increased IgY stability [30]. On the other hand, protein destruction by
trypsin, chymotrypsin, and pepsin could also be prevented by adding gum
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arabic [16]. By adding various agents, the effectiveness of the IgY gel might be
optimized, and further research should be conducted to enhance future IgY gel
formulations.
During saliva collection, higher saliva volumes were found in the IgY gel-
and plain gel-coated group. It is possible that the gel increased saliva production,
as well as played a role in reducing the caries risk. To our best knowledge, other
observations of rat saliva volumes have not been conducted to date [14, 22]. The
increase in saliva volume could have neutralized acidic conditions, which are a
cause of white spot lesions. In this study, the white spot lesions disappeared one
week after application of the IgY gel.
It has been proven by numerous experts in cariology that saliva is an agent
for caries prevention. According to Edgar [31], saliva contains, among other
things, various immunoglobulin and non-globulin anti-bacterial agents such as
amylase, lysosomes, lactoperoxidase, lactoferrin, apolactoferrin, and histatins.
Saliva prevents the formation of bioﬁlms that can cause caries. IgY gel could
inhibit the growth of S. mutans. Our research revealed the impact of anti-S. mutans
IgY gel and its prevention of dental caries in vitro, as well as in vivo, in Sprague
Dawley rats. Anti-S. mutans IgY gel still displayed reactivity levels similar to that
of pure IgY solution after being stored for 30 days at room temperature. The use of
additional media in the form of gels would not affect the content of pure IgY nor
change its biological properties. Given the various roles of IgY gel, it is expected
that this research could serve as a foundation for further investigation in humans.
Last, our results could be implemented in cariology experiments in the community.
The safety of anti-S. mutans IgY gel is adequate, given its lack of side effects, and
it is approved for use according to the FDA’s food-grade materials’ standards [32].
Conclusion
Topical application with anti-S. mutans IgY gel reduced the quantity of
S. mutans on the tooth surface.
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